Antivirals

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients receiving immunosuppressive therapy.

In the treatment of mpox, tecovirimat demonstrates superior toleration compared with other antivirals and may be the preferred treatment option for this disease, according to a study.